Celso Almeida has 20+ years of experience in the discovery of new bioactive microbial and photosynthetic-derived secondary natural products, with more than 45 new natural products isolated and characterized. With a PhD in Pharmaceutical Biology from the University of Bonn, Germany (magna cum laude), Celso has been developing startup-based business projects over the last 5 years, particularly in the discovery and early preclinical development of natural drug candidates, from new antibiotics to new solutions for central nervous system disorders.

At Greencolab, he will leverage state of the art pharmaceutical-grade tools for the discovery of new biological activities and possibly new natural products, for the functionalization of already commercialized algal products or assets in R&D. In one sentence, his main objective is to sustainably monetize and increase the productivity levels of algal assets already produced at the industrial scale, particularly through patents of use or products.